Nicotine Transdermal System Patch, Extended Release
NDC Package 36800-034-14
Package Information
Nicotine Transdermal System patches is this medication can help you quit smoking by replacing the nicotine in cigarettes. This formulation utilizes a patch, extended release delivery system. Marketed by Topco Associates Llc, this product is identified by NDC 36800-034 and is authorized under FDA application ANDA074612.
Identification & Billing
- RxCUI: 198029 - nicotine 14 MG/Day 24HR Transdermal System
- RxCUI: 198029 - 24 HR nicotine 0.583 MG/HR Transdermal System
- RxCUI: 198029 - nicotine 0.583 MG/HR 24HR Transdermal Patch
- RxCUI: 198029 - nicotine 14 MG per 24HR 1 Day Transdermal Patch
- RxCUI: 198030 - nicotine 21 MG/Day 24HR Transdermal System
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 36800 - Topco Associates Llc
- 36800-034 - Nicotine Transdermal System
- 36800-034-14 - 14 POUCH in 1 CARTON / 1 h in 1 POUCH
- 36800-034 - Nicotine Transdermal System
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 36800-034-14 identifies a specific commercial package of 14 pouch in 1 carton / 1 h in 1 pouch of Nicotine Transdermal System, a human over the counter drug labeled by Topco Associates Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This patch, extended release is formulated for transdermal use and contains nicotine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Topco Associates Llc on June 25, 2024. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication can help you quit smoking by replacing the nicotine in cigarettes. The nicotine in tobacco is an important part of cigarette addiction. When you stop smoking, your nicotine levels drop quickly. This drop can cause withdrawal symptoms such as craving tobacco, nervousness, irritability, headache, weight gain, and difficulty concentrating. Stopping smoking is hard and your chance of success is best when you are ready and have made a commitment to quit. Nicotine replacement products are part of a total stop-smoking program that includes behavior change, counseling, and support. Smoking causes lung disease, cancer, and heart disease. Stopping smoking is one of the most important things you can do to improve your health and live longer.
How is this Topco Associates Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 36800003414. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.